Literature DB >> 15606671

Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels.

Naohito Hatta1, Takashi Hirano, Tetsunori Kimura, Ken Hashimoto, Darius R Mehregan, Shinichi Ansai, Kazuhiko Takehara, Minoru Takata.   

Abstract

BACKGROUND: Distinguishing basal cell carcinoma (BCC) from other benign and malignant skin tumors is sometimes a difficult task for the pathologists. Because the activation of hedgehog signals and the up-regulation of its critical transcriptional factor Gli1 are well documented in BCC, a molecular technique measuring Gli1 transcripts may aide the diagnosis.
METHODS: Gli1 transcript levels were measured by real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) using RNA extracted from formalin-fixed, paraffin-embedded tissues of 68 cases of various skin tumors. Hematoxylin and eosin-stained pathology slides were independently reviewed by three expert dermatopathologists.
RESULTS: The histological diagnoses were unambiguous in 53 tumors. The tumors included BCC (21), squamous cell carcinoma (13), seborrheic keratoses (8), trichoepithelioma (5), eccrine poroma/porocarcinoma (4), and sebaceous epithelioma/carcinoma (2). In these unambiguous cases, all BCC and trichoepithelioma tumors showed high expression of Gli1mRNA, while the expression was virtually absent in other tumors. The diagnosis was discordant among three pathologists in the remaining 15 tumors. Histological diagnoses included BCC, BCC with sebaceous differentiation, sebaceoma/sebaceous epithelioma, trichoblastoma, trichoepithelioma, basaloid follicular harmartoma, basosquamous carcinoma, etc. Six of them showed high Gli1 transcript levels.
CONCLUSIONS: Quantification of Gli1 transcripts by RT-PCR is helpful in discriminating BCC and trichoepithelioma from other skin tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15606671     DOI: 10.1111/j.0303-6987.2005.00264.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  6 in total

Review 1.  Diagnosis and Management of Basal Cell Carcinoma.

Authors:  Keiji Tanese
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

2.  Markers for Sebaceoma Show a Spectrum of Cell Cycle Regulators, Tumor Suppressor Genes, and Oncogenes.

Authors:  Ana Maria Abreu Velez; Michael S Howard; Jinah Kim; Paul B Googe
Journal:  N Am J Med Sci       Date:  2015-06

3.  Neural Hedgehog signaling maintains stem cell renewal in the sensory touch dome epithelium.

Authors:  Ying Xiao; Daniel T Thoresen; Jonathan S Williams; Chaochen Wang; James Perna; Ralitsa Petrova; Isaac Brownell
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

Review 4.  Hedgehog-Gli signaling pathway inhibitors as anticancer agents.

Authors:  Neeraj Mahindroo; Chandanamali Punchihewa; Naoaki Fujii
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

5.  Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.

Authors:  Lorraine O'Driscoll; Jason McMorrow; Padraig Doolan; Eadaoin McKiernan; Jai Prakash Mehta; Eoin Ryan; Patrick Gammell; Helena Joyce; Norma O'Donovan; Nicholas Walsh; Martin Clynes
Journal:  Mol Cancer       Date:  2006-12-15       Impact factor: 27.401

6.  Downregulation of the Sonic Hedgehog/Gli pathway transcriptional target Neogenin-1 is associated with basal cell carcinoma aggressiveness.

Authors:  Bárbara S Casas; Christelle Adolphe; Pablo Lois; Nelson Navarrete; Natalia Solís; Eva Bustamante; Patricio Gac; Patricio Cabané; Ivan Gallegos; Brandon J Wainwright; Verónica Palma
Journal:  Oncotarget       Date:  2017-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.